Pharma Stocks News
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher
Sun Pharma has acquired Checkpoint Therapeutics for $355 million, enhancing its onco-dermatology portfolio with the FDA-approved drug UNLOXCYT. The deal, expected to close in 2025, reflects Sun Pharma’s strategy to strengthen its oncology presence and improve patient access to innovative treatments.
2 min read10 Mar 2025HSBC cuts Sun Pharma target price to ₹2,000 on macro uncertainties but still sees 24% upside. Time to buy?
HSBC lowered its target price for Sun Pharmaceuticals to ₹2,000, maintaining a ’buy’ rating. The revision reflects clinical trial delays and increased R&D investments, but the firm remains optimistic about growth from specialty brands despite potential downside risks.
2 min read7 Mar 2025Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur facility
Granules India’s shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing four concerns. The company confirmed progress in addressing these issues while maintaining product distribution.
2 min read28 Feb 2025Mankind Pharma gets NCLT nod for amalgamation of Shree Jee Lab, JPR Labs, Jaspack
The National Company Law Tribunal has approved the amalgamation of Shree Jee Laboratory, JPR Labs, and Jaspack Industries with Mankind Pharma.
1 min read28 Feb 2025Divi’s Labs share price dips 4% as SBI Mutual Fund trims stake in pharma company
Following a stake in Divi’s Labs by SBI Mutual Fund, shares of the pharma company dipped 4% today. India’s biggest mutual fund trimmed its stake by 0.0529% in Divi’s Labs, bringing its stake down to 5.0476%.
1 min read21 Feb 2025Small-cap stock below ₹50: Pharma stock jumps 6% from today’s low on this acquisition buzz
Small-cap stock below ₹50: Pharma stock , Sudarshan Pharma lndustries jumps 6% from lows in the stock market today on this acquisition buzz. It plans establish a wholly-owned subsidiary in Poland, a move aimed to broaden its business operations, potentially enhancing investor confidence
1 min read20 Feb 2025Stock market today: Sensex, Nifty 50 end volatile session flat; all eyes on Fed meet minutes
Indian markets experienced volatility on February 19, with the Sensex and Nifty 50 recovering from early losses to close flat. Financial stocks drove the recovery, while pharma and IT sectors faced declines. The Nifty 50 closed at 22,932 points, down 0.05%, and the Sensex at 75,955 points, up 0.02%.
3 min read19 Feb 2025Nifty Pharma index tanks over 3% on Trump’s 25% tariff threat; Aurobindo Pharma top loser
Indian pharma stocks faced selling pressure on February 19 after Trump announced potential tariffs on pharmaceutical imports. The Nifty Pharma index fell 3.2%, with major losses for Aurobindo Pharma and Lupin, amid concerns over ongoing trade protectionist measures impacting global trade.
2 min read19 Feb 2025Nifty Pharma drops over 2%, 19 index stocks tumble up to 7%. What triggered this fall?
Indian pharma stocks experienced heavy selling on February 10, influenced by weak earnings and concerns over possible U.S. tariffs. The Nifty Pharma index fell 2.10% with major firms like Alkem and Ipca suffering significant losses.
1 min read10 Feb 2025Small-cap stock under ₹50: Pharma stock jumps after CAPEX expansion update. Do you own?
Stock Market today: Small-cap stock under ₹50: Pharma stock Sigachi Industries share price is gaining momentum, buoyed by its recent CAPEX expansion for a R&D center. Analysts predict a price target, urging investors to watch closely as the stock aims to break past key resistance levels.
1 min read5 Feb 2025Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared